Schweitzer, L., & Muranski, P. (2024). Virus-specific T cell therapy to treat refractory viral infections in solid organ transplant recipients. American Journal of Transplantation. https://doi.org/10.1016/j.ajt.2024.05.019

Malagola, E., Vasciaveo, A., Ochiai, Y., Kim, W., Zheng, B., Zanella, L., Wang, A. L. E., Middelhoff, M., Nienhüser, H., Deng, L., Wu, F., Waterbury, Q. T., Belin, B., LaBella, J., Zamechek, L. B., Wong, M. H., Li, L., Guha, C., Cheng, C.-W., … Wang, T. C. (2024). Isthmus progenitor cells contribute to homeostatic cellular turnover and support regeneration following intestinal injury. Cell, 187(12), 3056-3071.e17. https://doi.org/10.1016/j.cell.2024.05.004

Carmichael, J., Figueiredo, I., Gurel, B., Beije, N., Yuan, W., Rekowski, J., Seed, G., Carreira, S., Bertan, C., Fenor de la Maza, M. de L. D., Chandran, K., Neeb, A., Welti, J., Gallagher, L., Bogdan, D., Crespo, M., Riisnaes, R., Ferreira, A., Miranda, S., … de Bono, J. (2024). RNASEH2B loss and PARP inhibition in advanced prostate cancer. Journal of Clinical Investigation. https://doi.org/10.1172/jci178278

Swartz, J. J., Huang, Y., Wu, J., Moss, H., Hershman, D. L., & Wright, J. D. (2024). Incidence of induced abortion among commercially insured pregnant patients with cancer. Contraception, 110511. https://doi.org/10.1016/j.contraception.2024.110511

White, D., Schiller, G. J., Madan, S., Lentzsch, S., Chubar, E., Lavi, N., Van Domelen, D. R., Bentur, O. S., & Baljevic, M. (2024). Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1352281

Rustgi, N., Wu, S., Samec, T., Walker, P., Xiu, J., Lou, E., Goel, S., Saeed, A., & Moy, R. H. (2024). Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer. Cancer Research Communications, 4(6), 1399–1409. https://doi.org/10.1158/2767-9764.crc-23-0496

Madarang, E., Lykon, J., Zhao, W., Sekeres, M. A., Bradley, T., Chandhok, N. S., Taylor, J., Venugopal, S., Koru-Sengul, T., Iyer, S. G., Gilbert, J. S., Miller, R. M., Nanni, J., Zacheo, I., Mattei, A., Al Ali, N., Kishtagari, A., Marconi, G., Sallman, D. A., … Watts, J. (2024). Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia. Blood Neoplasia, 1(2), 100016. https://doi.org/10.1016/j.bneo.2024.100016

Chen, L. N., Stanifer, B. P., Sonett, J. R., & Shu, C. A. (2024). Advancing neoadjuvant immunotherapy in non-small cell lung cancer (NSCLC): commentary on the Lung Cancer Mutation Consortium 3 trial (LCMC3). AME Clinical Trials Review, 2, 37–37. https://doi.org/10.21037/actr-24-13

Faber, E. B., Baca, Y., Xiu, J., Walker, P., Manji, G., Gholami, S., Saeed, A., Prakash, A., Botta, G. P., Sohal, D., Lenz, H. J., Shields, A. F., Nabhan, C., El-Deiry, W., Seeber, A., Chiu, V., Hwang, J., & Lou, E. (2024). Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status. ESMO Gastrointestinal Oncology, 4, 100042. https://doi.org/10.1016/j.esmogo.2024.100042

McGuinness, J. E., Anderson, G. L., Mutasa, S., Hershman, D. L., Terry, M. B., Tehranifar, P., Lew, D. L., Yee, M., Brown, E. A., Kairouz, S. S., Kuwajerwala, N., Bevers, T. B., Doster, J. E., Zarwan, C., Kruper, L., Minasian, L. M., Ford, L., Arun, B., Neuhouser, M. L., … Crew, K. D. (2024). Effects of vitamin D supplementation on a deep learning–based mammographic evaluation in SWOG S0812. JNCI Cancer Spectrum, 8(4). https://doi.org/10.1093/jncics/pkae042

Walsh, Z. H., Shah, P., Kothapalli, N., Shah, S. B., Nikolenyi, G., Brodtman, D. Z., Leuzzi, G., Rogava, M., Mu, M., Ho, P., Abuzaid, S., Vasan, N., AlQuraishi, M., Milner, J. D., Ciccia, A., Melms, J. C., & Izar, B. (2024). Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens. Nature Biotechnology. https://doi.org/10.1038/s41587-024-02235-x

Abate-Shen, C., & Politi, K. (2024). The Evolution of Mouse Models of Cancer: Past, Present, and Future. Cold Spring Harbor Perspectives in Medicine, a041736. https://doi.org/10.1101/cshperspect.a041736

Bazarbachi, A., Labopin, M., Raiola, A. M., Blaise, D., Arcese, W., Santarone, S., Koc, Y., Bramanti, S., Kulagin, A., Kwon, M., Sica, S., Sanz, J., Brissot, E., Nagler, A., Ciceri, F., & Mohty, M. (2024). Posttransplant cyclophosphamide versus anti‐thymocyte globulin versus combination for graft‐versus‐host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party. Cancer. Portico. https://doi.org/10.1002/cncr.35365

Neo, S. Y., Tong, L., Chong, J., Liu, Y., Jing, X., Oliveira, M. M. S., Chen, Y., Chen, Z., Lee, K., Burduli, N., Chen, X., Gao, J., Ma, R., Lim, J. P., Huo, J., Xu, S., Alici, E., Wickström, S. L., Haglund, F., … Lundqvist, A. (2024). Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis. Science Translational Medicine, 16(747). https://doi.org/10.1126/scitranslmed.adi2952

Rosenberger, G., Li, W., Turunen, M., He, J., Subramaniam, P. S., Pampou, S., Griffin, A. T., Karan, C., Kerwin, P., Murray, D., Honig, B., Liu, Y., & Califano, A. (2024). Network-based elucidation of colon cancer drug resistance mechanisms by phosphoproteomic time-series analysis. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-47957-3

Suzuki, Y., Ferris, J. S., Chen, L., Dioun, S., Usseglio, J., Matsuo, K., Xu, X., Hershman, D. L., & Wright, J. D. (2024). Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis. JNCI: Journal of the National Cancer Institute, 116(5), 653–664. https://doi.org/10.1093/jnci/djae023

Yaron-Barir, T. M., Joughin, B. A., Huntsman, E. M., Kerelsky, A., Cizin, D. M., Cohen, B. M., Regev, A., Song, J., Vasan, N., Lin, T.-Y., Orozco, J. M., Schoenherr, C., Sagum, C., Bedford, M. T., Wynn, R. M., Tso, S.-C., Chuang, D. T., Li, L., Li, S. S.-C., … Johnson, J. L. (2024). The intrinsic substrate specificity of the human tyrosine kinome. Nature, 629(8014), 1174–1181. https://doi.org/10.1038/s41586-024-07407-y

Dunbar, A. J., Bowman, R. L., Park, Y. C., O’Connor, K., Izzo, F., Myers, R. M., Karzai, A., Zaroogian, Z., Kim, W. J., Fernández-Maestre, I., Waarts, M. R., Nazir, A., Xiao, W., Codilupi, T., Brodsky, M., Farina, M., Cai, L., Cai, S. F., Wang, B., … Levine, R. L. (2024). Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms. Cancer Discovery, 14(5), 737–751. https://doi.org/10.1158/2159-8290.cd-22-0952

Nakagawa, S., Carnevali, D., Tan, X., Alvarez, M. J., Parfitt, D.-E., Di Vicino, U., Arumugam, K., Shin, W., Aranda, S., Normanno, D., Sebastian-Perez, R., Cannatá, C., Cortes, P., Neguembor, M. V., Shen, M. M., Califano, A., & Cosma, M. P. (2024). The Wnt-dependent master regulator NKX1-2 controls mouse pre-implantation development. Stem Cell Reports, 19(5), 689–709. https://doi.org/10.1016/j.stemcr.2024.04.004

Spotnitz, M., Ekanayake, C. D., Ostropolets, A., McKhann, G. M., Choi, H., Ottman, R., Neugut, A. I., Hripcsak, G., Natarajan, K., & Youngerman, B. E. (2024). Use of Recommended Neurodiagnostic Evaluation Among Patients With Drug-Resistant Epilepsy. JAMA Neurology, 81(5), 499. https://doi.org/10.1001/jamaneurol.2024.0551

Riabov, V., Xu, Q., Schmitt, N., Streuer, A., Ge, G., Bolanos, L., Wunderlich, M., Jann, J.-C., Wein, A., Altrock, E., Demmerle, M., Mukherjee, S., Ali, A. M., Rapp, F., Nowak, V., Weimer, N., Obländer, J., Palme, I., Göl, M., … Nowak, D. (2023). <i>ASXL1</i> mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms. Haematologica, 0–0. https://doi.org/10.3324/haematol.2023.282921

Neugut, A. I., & Fojo, T. (2024). The statistical significance revolution. JNCI Cancer Spectrum, 8(3). https://doi.org/10.1093/jncics/pkae035

Kinslow, C. J., DeStephano, D. M., Neugut, A. I., Taparra, K., Horowitz, D. P., Yu, J. B., & Cheng, S. K. (2024). Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic. JNCI Cancer Spectrum, 8(3). https://doi.org/10.1093/jncics/pkae022

Baird, C. E., Wulff-Burchfield, E., Egan, P. C., Hugar, L. A., Vyas, A., Trikalinos, N. A., Liu, M. A., Bélanger, E., Olszewski, A. J., Bantis, L. E., & Panagiotou, O. A. (2024). Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study. Journal of Geriatric Oncology, 15(5), 101774. https://doi.org/10.1016/j.jgo.2024.101774

Cherng, H.-J. J., & Herrera, A. (2024). Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside? Current Treatment Options in Oncology, 25(5), 659–678. https://doi.org/10.1007/s11864-024-01201-8

Frangoul, H., Locatelli, F., Sharma, A., Bhatia, M., Mapara, M., Molinari, L., Wall, D., Liem, R. I., Telfer, P., Shah, A. J., Cavazzana, M., Corbacioglu, S., Rondelli, D., Meisel, R., Dedeken, L., Lobitz, S., de Montalembert, M., Steinberg, M. H., Walters, M. C., … Grupp, S. A. (2024). Exagamglogene Autotemcel for Severe Sickle Cell Disease. New England Journal of Medicine, 390(18), 1649–1662. https://doi.org/10.1056/nejmoa2309676

Keller, M. D., Hanley, P. J., Chi, Y.-Y., Aguayo-Hiraldo, P., Dvorak, C. C., Verneris, M. R., Kohn, D. B., Pai, S.-Y., Dávila Saldaña, B. J., Hanisch, B., Quigg, T. C., Adams, R. H., Dahlberg, A., Chandrakasan, S., Hasan, H., Malvar, J., Jensen-Wachspress, M. A., Lazarski, C. A., Sani, G., … Pulsipher, M. A. (2024). Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-47057-2

Wu, L. W., Tao, J. J., McDonnell, D., & Izar, B. (2024). Pseudoprogression in a patient with metastatic melanoma treated with PD-1 and LAG-3 inhibition. Melanoma Research, 34(4), 382–385. https://doi.org/10.1097/cmr.0000000000000974

Charalampous, C., Shah, D., Kumar, S., & Chakraborty, R. (2024). Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines. Annals of Hematology. https://doi.org/10.1007/s00277-024-05733-9

Zhang, F., Sahu, V., Peng, K., Wang, Y., Li, T., Bala, P., Aitymbayev, D., Sahgal, P., Schaefer, A., Der, C. J., Ryeom, S., Yoon, S., Sethi, N., Bass, A. J., & Zhang, H. (2024). Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Gut, 73(8), 1280–1291. https://doi.org/10.1136/gutjnl-2023-329686

Trivedi, M. S., Manley, H., Yi, H., Silverman, T., Chung, W. K., Appelbaum, P. S., Starck, R., Schecter, I., Kukafka, R., & Crew, K. D. (2024). Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women. Familial Cancer. https://doi.org/10.1007/s10689-024-00371-6

Liu, M. A., Li, J. W., & Runcie, K. (2024). Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma. Current Oncology Reports, 26(5), 496–503. https://doi.org/10.1007/s11912-024-01523-8

Vadivel, C. K., Willerslev-Olsen, A., Namini, M. R. J., Zeng, Z., Yan, L., Danielsen, M., Gluud, M., Pallesen, E. M. H., Wojewoda, K., Osmancevic, A., Hedebo, S., Chang, Y.-T., Lindahl, L. M., Koralov, S. B., Geskin, L. J., Bates, S. E., Iversen, L., Litman, T., Bech, R., … Buus, T. B. (2024). Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome. Blood, 143(15), 1496–1512. https://doi.org/10.1182/blood.2023021671

Wasko, U. N., Jiang, J., Dalton, T. C., Curiel-Garcia, A., Edwards, A. C., Wang, Y., Lee, B., Orlen, M., Tian, S., Stalnecker, C. A., Drizyte-Miller, K., Menard, M., Dilly, J., Sastra, S. A., Palermo, C. F., Hasselluhn, M. C., Decker-Farrell, A. R., Chang, S., Jiang, L., … Olive, K. P. (2024). Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Nature, 629(8013), 927–936. https://doi.org/10.1038/s41586-024-07379-z

Ali, A. M., & Raza, A. (2024). scRNAseq and High-Throughput Spatial Analysis of Tumor and Normal Microenvironment in Solid Tumors Reveal a Possible Origin of Circulating Tumor Hybrid Cells. Cancers, 16(7), 1444. https://doi.org/10.3390/cancers16071444

Xu, J. J., & Viny, A. D. (2024). Chromatin organization in myelodysplastic syndrome. Experimental Hematology, 134, 104216. https://doi.org/10.1016/j.exphem.2024.104216

Lichtenstein, M. R. L., Levit, L. A., Schenkel, C., Kirkwood, K., Fashoyin-Aje, L. A., Bruinooge, S. S., Kelley, M. J., Mailman, J. A., Magnuson, A., Mirda, D. P., Natesan, D., & Hershman, D. L. (2023). Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials. The Oncologist, 29(4), 356–363. https://doi.org/10.1093/oncolo/oyad237

Robey, R. W., Fitzsimmons, C. M., Guiblet, W. M., Frye, W. J. E., González Dalmasy, J. M., Wang, L., Russell, D. A., Huff, L. M., Perciaccante, A. J., Ali-Rahmani, F., Lipsey, C. C., Wade, H. M., Mitchell, A. V., Maligireddy, S. S., Terrero, D., Butcher, D., Edmondson, E. F., Jenkins, L. M., Nikitina, T., … Batista, P. J. (2023). The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors. Molecular Cancer Therapeutics, 23(4), 464–477. https://doi.org/10.1158/1535-7163.mct-23-0144

Papachristodoulou, A., Heidegger, I., Virk, R. K., Di Bernardo, M., Kim, J. Y., Laplaca, C., Picech, F., Schäfer, G., De Castro, G. J., Hibshoosh, H., Loda, M., Klocker, H., Rubin, M. A., Zheng, T., Benson, M. C., McKiernan, J. M., Dutta, A., & Abate-Shen, C. (2024). Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. European Urology, 85(4), 361–372. https://doi.org/10.1016/j.eururo.2023.07.016

Trivedi, M. S., & Armstrong, K. A. (2024). Increasing the Uptake of Cancer Risk Management Strategies for Women With BRCA1/2 Sequence Variations. JAMA Oncology, 10(4), 435. https://doi.org/10.1001/jamaoncol.2023.5186

Atkins, M. B., Jegede, O. A., Haas, N. B., Mcdermott, D. F., Bilen, M. A., Stein, M., Sosman, J., Alter, R., Plimack, E. R., Ornstein, M. C., Hurwitz, M., Peace, D. J., Einstein, D., Catalano, P. J., Hammers, H., & Regan, M. M. (2024). Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A). Journal for ImmunoTherapy of Cancer, 12(4), e008293. https://doi.org/10.1136/jitc-2023-008293

Xiao, H., Vaidya, R., Hershman, D. L., & Unger, J. M. (2024). Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022. Journal of Clinical Oncology, 42(16), 1953–1960. https://doi.org/10.1200/jco.23.01777

Kim, A. E., Bennett, J. C., Luiten, K., O’Hanlon, J. A., Wolf, C. R., Magedson, A., Han, P. D., Acker, Z., Regelbrugge, L., McCaffrey, K. M., Stone, J., Reinhart, D., Capodanno, B. J., Morse, S. S., Bedford, T., Englund, J. A., Boeckh, M., Starita, L. M., Uyeki, T. M., … Chu, H. Y. (2024). Comparative Diagnostic Utility of SARS-CoV-2 Rapid Antigen and Molecular Testing in a Community Setting. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae150

Lee, K. T., Gonzalez, B. D., Geiss, C., Fulton, H. J., Charles, D., Vadaparampil, S. T., Henry, N. L., Jim, H. S. L., Hershman, D. L., Tworoger, S. S., & Gwede, C. K. (2024). Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providers. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-024-01574-7

Mata, J. R., Zahurak, M., Rosen, N., DeZern, A. E., Jones, R. J., & Ambinder, A. J. (2024). Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. Transplantation and Cellular Therapy, 30(6), 588–596. https://doi.org/10.1016/j.jtct.2024.03.018

Ryu Tiger, Y. K., Jain, S., Barta, S. K., Tolu, S., Estrella, B., Sawas, A., Lue, J. K., Francescone, M. M., Pro, B., & Amengual, J. E. (2024). Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma. Leukemia & Lymphoma, 65(6), 736–745. https://doi.org/10.1080/10428194.2024.2329996

Fojo, T., LaRose, M., & Bates, S. E. (2024). The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype. The Oncologist, 29(4), 275–277. https://doi.org/10.1093/oncolo/oyae042

Reed, A. E., Peraza, J., van den Haak, F., Hernandez, E. R., Gibbs, R. A., Chinn, I. K., Lupski, J. R., Marchi, E., Reshef, R., Alobeid, B., Mace, E. M., & Orange, J. S. (2024). β-Actin G342D as a Cause of NK Cell Deficiency Impairing Lytic Synapse Termination. The Journal of Immunology, 212(6), 962–973. https://doi.org/10.4049/jimmunol.2300671

Pinheiro, L. C., An, A., Zeng, C., Walker, D., Mercurio, A. M., Hershman, D. L., & Rosenberg, S. M. (2024). Racial and Ethnic Differences in Psychosocial Care Use Among Adults With Metastatic Breast Cancer: A Retrospective Analysis Across Six New York City Health Systems. JCO Oncology Practice, 20(7), 984–991. https://doi.org/10.1200/op.23.00528

Arriaga, J. M., Ronaldson-Bouchard, K., Picech, F., Nunes de Almeida, F., Afari, S., Chhouri, H., Vunjak-Novakovic, G., & Abate-Shen, C. (2024). In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis. Oncogene, 43(17), 1303–1315. https://doi.org/10.1038/s41388-024-02995-5